Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury

Laboratory Investigation

Volumn 85, Issue 10, 2005, Pages 1250-1262

  Mota, Ruben A ^a   Sánchez Bueno, Francisco ^a   Saenz, Luis ^a   Hernández Espinosa, David ^a   Jimeno, Jaime ^a   Tornel, Pedro L ^a   Martínez Torrano, Alejandro ^a   Ramírez, Pablo ^a   Parrilla, Pascual ^a   Yélamos, José ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Acute pancreatitis; Inflammation; Lung injury; Poly(ADP ribose)polymerase

Indexed keywords

3 AMINOBENZAMIDE; CERULETIDE; MYELOPEROXIDASE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; HISTOPATHOLOGY; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WATER CONTENT; WILD TYPE;

ACUTE DISEASE; AMYLASES; ANIMALS; BENZAMIDES; CAERULEIN; INTERLEUKIN-1; INTERLEUKIN-6; LIPASE; LUNG DISEASES; MICE; MICE, KNOCKOUT; NEUTROPHILS; PANCREATITIS; PEROXIDASE; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES;

EID: 25144433997     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700326     Document Type: Article

References (45)

1. Imrie CW. Acute pancreatitis: overview. Eur J Gastroenterol Hepatol 1997;9:103-105.
2. Steer M. Pancreatitis severity: who calls the shots? Gastroenterology 2002;122:1168-1172.
3. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
4. Zaninovic V, Gukovskaya AS, Gukovsky I, et al. Cerulein upregulated ICAM-1 in pancreatic acinar cells, which mediates neutrophils adhesion to these cells. Am J Physiol 2000;279:G666-G676.
5. Gukovskaya AS, Vaquero E, Zaninovic V, et al. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 2002;122:974-984.
6. Frossard JL, Saluja A, Bhagat L, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999;116:694-701.
7. Bathia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-125.
8. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853-6866.
9. Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNF-α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 1996;171:274-280.
10. Denharn W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin N Am 1999;79:767-781.
11. Gukovsky I, Gukovskaya AS, Blinman TA, et al. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998;275:G1402-G1414.
12. Satoh A, Shimosegawa T, Fujita M, et al. Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis. Gut 1999;44:253-258.
13. Ethridge RT, Hashimoto K, Chung DH, et al. Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. Am J Coll Surg 2002;195:497-505.
14. Altavilla D, Famulari C, Passaniti M, et al. Attenuated cerulein-induced pancreatitis in nuclear factor-κB-deficient mice. Lab Invest 2003;12:1723-1732.
15. Oliver FJ, Menissier-de Murcia J, Nacci C, et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999;18:4446-4454.
16. Corral J, Yélamos J, Hernández-Espinosa D, et al. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol 2005;166:1089-1098.
17. Carrillo A, Monreal Y, Ramirez P, et al. Transcription regulation of TNF-α-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleid Acids Res 2004;32:757-766.
18. Soriano FG, Liaudet L, Szabo E, et al. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002;17:286-292.
19. Veres B, Gallyas Jr F, Varbiro G, et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003;65:1373-1382.
20. de Murcia G, Shall S. From DNA Damage and Stress Signalling to Cell Death: Poly(ADP-Ribosylation) Reactions. Oxford University Press: Oxford, 2000.
21. Amé JC, Rolli V, Schreiber V, et al. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 1999;274:17860-17868.
22. Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays 2004;26:1-12.
23. Schreiber V, Amé JC, Dollé P, et al. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 2002;277:23028-23036.
24. Menissier de Murcia J, Ricoul M, Tartier L, et al. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 2003;22:2255-2263.
25. Garcia Soriano F, Virág L, Jagtap P, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001;7:108-113.
26. Jagtap P, Garcia Soriano F, Virág L, et al. Novel phenanthridinone inhibitors of poly(adenosine 5-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 2002;30:1071-1082.
27. Purnell MR, Whish WJ. Novel inhibitors of poly(ADP-ribose) synthetase. Biochem J 1980;185:775-777.
28. Menissier-de Murcia J, Niedergang C, Trucco C, et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997;94:7303-7307.
29. Cuzzocrea S, Zingarelli B, Gilad E, et al. Protective effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 1998;342:67-76.
30. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-1922.
31. Steer ML. Models for the study of pancreatitis. In: Souba W, Wilmore D (eds). Surgical Research. Academic Press: San Diego, CA, 2001, pp 733-746.
32. Liaudet L, Pacher P, Mabley JG, et al. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002;165:372-377.
33. Grady T, Saluja A, Kaiser A, et al. Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis. Am J Physiol 1996;271:G20-G26.
34. Popoff I, Jijon H, Monia B, et al. Antisense oligonucleotides to poly(ADP-ribose) polymerase-2 ameliorate colitis in interleukin-10-deficient mice. J Pharmacol Exp Ther 2002;303:1145-1154.
35. Ethridge RT, Chung DH, Slogoff M, et al. Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 2002;123:1311-1322.
36. Wagner AC, Mazzucchelli L, Miller M, et al. CEP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am J Physiol 2000;278:G165-G172.
37. Banasik M, Komura H, Shimoyama M, et al. Specific inhibitors of poly(ADP-ribose) synthetase and mono (ADP-ribosyl)transferase. J Biol Chem 1992;267:1569-1575.
38. Iwashita A, Tojo N, Matsuura S, et al. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6- dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther 2004;310:425-436.
39. Sharp C, Warren A, Oshima T, et al. Poly ADP ribose-polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. Inflammation 2001;25:157-163.
40. Haskó G, Mabley JG, Németh ZH, et al. Poly(ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol Med 2002;8:283-289.
41. Szabó C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998;19:287-297.
42. Hwang JJ, Choi SY, Koh JY. The role of NADPH oxidase, neuronal nitric oxide synthase and poly(ADP ribose) polymerase in oxidative neuronal death induced in cortical cultures by brain-derived neurotrophic factor and neurotrophin-4/5. J Nerochem 2002;82:894-902.
43. de Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
44. Inagaki T, Hoshino M, Hayakawa T, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 1997;14:1-8.
45. Cuzzocrea S, Mazzon E, Dugo L, et al. Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice. Cytokine 2002;18:274-285.